Featured Research

from universities, journals, and other organizations

Using Tablets, Telemedicine to Speed Stroke Treatment

Date:
January 6, 2014
Source:
University of Virginia Health System
Summary:
A team is working with local rescue squads to diagnose stroke patients before they reach the hospital, enabling more patients to receive lifesaving treatment and have a full recovery. The goal: Connect paramedics through a secure video link with specially trained stroke neurologists and emergency medicine physicians, who can diagnose stroke patients while they’re in the ambulance and enable treatment to begin as soon as patients arrive at the hospital.

A University of Virginia Health System team is working with local rescue squads to diagnose stroke patients before they reach the hospital, enabling more patients to receive lifesaving treatment and have a full recovery.

Working through UVA Innovation's USEED fundraising program, UVA clinicians are raising $10,000 to equip two additional local ambulances with the iTREAT mobile telemedicine kit. The goal: Connect paramedics through a secure video link with UVA's specially trained stroke neurologists and emergency medicine physicians, who can diagnose stroke patients while they're in the ambulance and enable treatment to begin as soon as patients arrive at the hospital.

"The longest delay in treating folks is not once they get to the hospital but before they get to the hospital," said stroke neurologist Andrew Southerland, MD.

Why Is a Speedy Diagnosis Important?

Fast diagnosis and treatment is vital because the most effective treatment for acute ischemic stroke patients -- the clot-busting drug tPA -- is only safe and effective if delivered within three hours of when symptoms begin. Due to delays in reaching a hospital and receiving a diagnosis, less than 5 percent of all stroke patients receive tPA.

Getting stroke patients treated quickly is even more challenging for patients living in remote, rural areas of central and southwest Virginia, where it may take an ambulance 30 minutes or longer to get patients to an emergency room or stroke center. "iTREAT is really designed to help support patients from rural communities to get the care they need quickly," said David Cattell-Gordon, director of the UVA Office of Telemedicine. "Every minute in a stroke matters."

Connecting Stroke Neurologists, ER Doctors with Patients The iTREAT seeks to make productive use of those long ambulance transports to diagnose stroke patients. The UVA partners -- the UVA Stroke Center, UVA Department of Emergency Medicine and the UVA Center for Telehealth -- are working with the Thomas Jefferson Council for Emergency Medical Services to equip regional rescue squads with the iTREAT mobile telemedicine toolkit. Equipment includes a tablet device, secure videoconferencing technology, a high-speed modem, and a magnetic antenna to mount on the outside of the ambulance.

UVA and the Thomas Jefferson Council are working to equip a total of 12 ambulances in Albemarle, Greene, Louisa and Nelson counties with the iTREAT toolkit, said Sherita Chapman, MD, a vascular medicine fellow at UVA. "What we're trying to improve is treatment times for stroke patients [in these counties]," she said. Southerland estimates it will cost about $5,000 to equip each additional ambulance with the iTREAT equipment.

Faster Care for a Variety of Patients The iTREAT technology is in the testing stage with local rescue squads, Southerland said, with the hope of using it to care for Central Virginia patients in early 2014. "If iTREAT is successful, we hope it can become a model for using telehealth to speed treatment for a range of emergency medical conditions," Southerland said.


Story Source:

The above story is based on materials provided by University of Virginia Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Virginia Health System. "Using Tablets, Telemedicine to Speed Stroke Treatment." ScienceDaily. ScienceDaily, 6 January 2014. <www.sciencedaily.com/releases/2014/01/140106132802.htm>.
University of Virginia Health System. (2014, January 6). Using Tablets, Telemedicine to Speed Stroke Treatment. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/01/140106132802.htm
University of Virginia Health System. "Using Tablets, Telemedicine to Speed Stroke Treatment." ScienceDaily. www.sciencedaily.com/releases/2014/01/140106132802.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins